These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33744848)
1. lncRNA OGFRP1 promotes tumor progression by activating the AKT/mTOR pathway in human gastric cancer. Zhang J; Xu X; Yin J; Tang J; Hu N; Hong Y; Song Z; Bian B; Wu F Aging (Albany NY); 2021 Mar; 13(7):9766-9779. PubMed ID: 33744848 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs. Zhang X; Liu J; Gu Y; Sun C; Qu F Cell Biol Int; 2019 Feb; 43(2):158-166. PubMed ID: 30536541 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway. Meng Q; Xue H Technol Cancer Res Treat; 2020; 19():1533033820905823. PubMed ID: 32233835 [TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway. Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636 [TBL] [Abstract][Full Text] [Related]
6. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543 [TBL] [Abstract][Full Text] [Related]
7. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway. Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435 [TBL] [Abstract][Full Text] [Related]
8. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102 [TBL] [Abstract][Full Text] [Related]
9. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434 [TBL] [Abstract][Full Text] [Related]
10. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway. Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766 [TBL] [Abstract][Full Text] [Related]
11. LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis. Qin H; Li X; Zhang W; Ding Z J Mol Histol; 2022 Apr; 53(2):257-271. PubMed ID: 35050465 [TBL] [Abstract][Full Text] [Related]
12. LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression. Ba MC; Ba Z; Long H; Cui SZ; Gong YF; Yan ZF; Lin KP; Wu YB; Tu YN Cell Death Dis; 2020 Jan; 11(1):64. PubMed ID: 31988283 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
14. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway. Rong L; Li Z; Leng X; Li H; Ma Y; Chen Y; Song F Biomed Pharmacother; 2020 Feb; 122():109726. PubMed ID: 31918283 [TBL] [Abstract][Full Text] [Related]
15. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway. Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2. Qu F; Cao P Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828 [TBL] [Abstract][Full Text] [Related]
17. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290 [TBL] [Abstract][Full Text] [Related]
18. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis. Yao X; Yan C; Zhang L; Li Y; Wan Q Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625 [TBL] [Abstract][Full Text] [Related]
19. BAIAP2L2 promotes the progression of gastric cancer via AKT/mTOR and Wnt3a/β-catenin signaling pathways. Liu J; Shangguan Y; Sun J; Cong W; Xie Y Biomed Pharmacother; 2020 Sep; 129():110414. PubMed ID: 32570120 [TBL] [Abstract][Full Text] [Related]
20. LncRNA-LOC101928316 contributes to gastric cancer progression through regulating PI3K-Akt-mTOR signaling pathway. Li C; Liang G; Yang S; Sui J; Wu W; Xu S; Ye Y; Shen B; Zhang X; Zhang Y Cancer Med; 2019 Aug; 8(9):4428-4440. PubMed ID: 31207155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]